Enanta Pharma (ENTA) Tops Q1 EPS by 10c, Revenues Miss

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 11/4/2026

1. AMD
2. AMGN
3. BKNG
4. DOX
5. DUOL
6. ANET
7. XYZ
8. SWKS
9. FISV
10. CVS

Go back to Enanta Pharma (ENTA) Tops Q1 EPS by 10c, Revenues Miss

Enanta Pharmaceuticals Reports Financial Results for its Fiscal First Quarter and Three Months Ended December 31, 2019

February 6, 2020 4:00 PM EST

Webcast and Conference Call Today at 4:30 p.m. ET

Positive results from part 1 of the Phase 1a/b clinical study of EDP-514 in healthy subjects
- Part 2 initiated in nuc-suppressed chronic hepatitis B virus patients Research and development programs progressing well -- several milestones expected in 2020 from our RSV, NASH, and HBV programs Royalty revenue for the quarter was $52.6 million Cash and marketable securities totaled $414.7 million at December 31, 2019

WATERTOWN, Mass.--(BUSINESS WIRE)-- Enanta Pharmaceuticals, Inc. (NASDAQ:... More